Moreover, MAPK-p38 pathway has been endowed with growth inhibitory properties, thus, its progressive abolishment might lead Delta16HER2 cancers first to grow and replicate quickly at early stages of tumorigenesis, while triggering senescence at later stages (Fig. S4A–D, additional blots in Supplementary Information). This evidence concerns the gene MAPK14 and cancer.